Prelude Therapeutics, Inc. (PRLD)
4.70
-0.17
(-3.49%)
USD |
NASDAQ |
Sep 21, 16:00
4.73
+0.03
(+0.64%)
After-Hours: 20:00
Prelude Therapeutics Market Cap : 374.86M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 21, 2026 | 374.86M |
| September 18, 2026 | 388.42M |
| September 17, 2026 | 364.49M |
| September 16, 2026 | 356.51M |
| September 15, 2026 | 360.50M |
| September 14, 2026 | 366.09M |
| September 11, 2026 | 366.09M |
| September 10, 2026 | 372.47M |
| September 09, 2026 | 405.96M |
| September 08, 2026 | 422.71M |
| September 04, 2026 | 435.47M |
| September 03, 2026 | 418.72M |
| September 02, 2026 | 433.08M |
| September 01, 2026 | 437.87M |
| August 31, 2026 | 446.64M |
| August 28, 2026 | 436.27M |
| August 27, 2026 | 505.66M |
| August 26, 2026 | 523.21M |
| August 25, 2026 | 525.60M |
| August 24, 2026 | 516.03M |
| August 21, 2026 | 528.79M |
| August 20, 2026 | 518.42M |
| August 19, 2026 | 461.00M |
| August 18, 2026 | 458.60M |
| August 17, 2026 | 449.03M |
| Date | Value |
|---|---|
| August 14, 2026 | 442.65M |
| August 13, 2026 | 427.50M |
| August 12, 2026 | 457.01M |
| August 11, 2026 | 424.31M |
| August 10, 2026 | 385.23M |
| August 07, 2026 | 390.81M |
| August 06, 2026 | 373.26M |
| August 05, 2026 | 286.10M |
| August 04, 2026 | 284.84M |
| August 03, 2026 | 276.65M |
| July 31, 2026 | 289.88M |
| July 30, 2026 | 318.24M |
| July 29, 2026 | 296.82M |
| July 28, 2026 | 292.40M |
| July 27, 2026 | 245.14M |
| July 24, 2026 | 241.36M |
| July 23, 2026 | 247.66M |
| July 22, 2026 | 247.35M |
| July 21, 2026 | 254.59M |
| July 20, 2026 | 255.85M |
| July 17, 2026 | 264.68M |
| July 16, 2026 | 263.42M |
| July 15, 2026 | 281.06M |
| July 14, 2026 | 276.65M |
| July 13, 2026 | 279.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Q32 Bio, Inc. | 248.52M |
| Intellia Therapeutics, Inc. | 1.711B |
| Twist Bioscience Corp. | 10.39B |
| Beam Therapeutics, Inc. | 2.608B |
| Revolution Medicines, Inc. | 41.30B |
Market Cap Related Metrics
| PS Ratio | 16.77 |
| Price to Book Value | 2.803 |
| Price | 4.70 |
| Earnings Yield | -16.76% |